MedPath

The effect of modulating hepatic glycogen content on hepatic fat oxidatio

Completed
Conditions
fatty liver
Non-alcoholic fatty liver (NAFL)
10019654
10013317
Registration Number
NL-OMON45924
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
34
Inclusion Criteria

- Signed informed consent
- Caucasian (people will be excluded when having a *50% racial African/Asian background)
- Male or postmenopausal female
- Aged 45-75 years at start of the study
- Body mass index (BMI) 27 * 38 kg/m2
- Stable dietary habits (no weight loss or gain >3kg in the past 3 months)
- Sedentary lifestyle (not more than 2 hours of sports per week)
- Liver fat *5% as determined by 1H-MRS

Exclusion Criteria

- Type 2 diabetes
- Active diseases (cardiovascular, diabetes, liver, kidney, cancer or other)
- Contra-indication for MRI
- Alcohol consumption of >2 servings per day
- Regular smoking (>5 cigarettes per day)
- No use of medication interfering with investigated study parameters (as determined by responsible physician)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath